Journals of Gerontology Series A: Biological Sciences and Medical Sciences Large Type Edition
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bartke, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bartke, A.
The Journals of Gerontology Series A: Biological Sciences and Medical Sciences 60:133-134 (2005)
© 2005 The Gerontological Society of America


LETTER TO THE EDITOR

INSULIN RESISTANCE AND COGNITIVE AGING IN LONG-LIVED AND SHORT-LIVED MICE

Andrzej Bartke, PhD

Geriatrics Research Department of Internal Medicine Southern Illinois University School of Medicine Springfield, Illinois

Address correspondence to Andrzej Bartke, PhD, Geriatrics Research, Department of Internal Medicine, SIU School of Medicine, P.O. Box 19628, 801 N. Rutledge, Rm. 4389, Springfield, IL 62794-9628. E-mail: abartke{at}siumed.edu

To the Editor:

In a recent Future History article in this Journal, Rasgon and Jarvik (1) suggested that insulin resistance may facilitate the onset of Alzheimer's disease (AD) and may provide a mechanistic link between affective disorders and AD. In this context, it may be interesting to examine the association between alterations in insulin signaling and in cognitive aging in mice with major, genetically determined differences in these parameters.

Hypopituitary Ames dwarf (Prop1df) mice and growth hormone receptor knock-out (GHR-KO) mice have enhanced sensitivity to insulin. In these animals, both plasma insulin and plasma glucose levels are reduced (2–7), injections of insulin cause greater suppression of plasma glucose levels than is observed in normal mice from the same stocks (7,8), and acute stimulation of early steps of insulin signaling in the liver by exogenous insulin is markedly enhanced (6,7). The effects of aging on learning ability and memory of these animals were examined using a passive avoidance task. In contrast to normal animals that exhibited the expected age-related decline of performance on this test, both Ames dwarf and GHR-KO mice maintained unaltered levels of cognitive function into advanced age (9,10). Young adult Ames dwarf and GHR-KO mice did not differ from normal animals of the same age in their ability to learn and remember, as assessed by this task. A recent study of GHR-KO mice confirmed these observations using a Morris water maze, a behavioral test designed to assess learning and spatial memory (11). Results of additional studies indicated that the superior cognitive ability of old Ames dwarf and GHR-KO mice as compared with old normal animals was not due to differences in locomotor activity, emotionality, pain thresholds, swimming speed, or other confounders (9–11). Thus, in two types of mutant mice, enhanced insulin sensitivity is associated with greatly attenuated and delayed cognitive aging. If these associations represent cause–effect relationships, the possible mechanistic links may include reduced insulin release and consequent reduction of insulin signaling in the brain (Al-Regaiey, Masternak, and Bartke, unpublished observations) and reduced oxidative damage to brain cells (12).

In contrast to growth hormone (GH)-deficient hypopituitary Ames dwarf mice and GH-resistant GHR-KO mice that are insulin sensitive, giant transgenic mice over-expressing GH are insulin resistant. In GH transgenic mice, plasma insulin levels are grossly elevated, while glucose levels are generally normal. Studies of early steps of insulin signaling demonstrated insulin resistance in the liver and in the skeletal muscle of these animals (13,14). Behavioral tests of GH transgenic mice revealed excellent learning ability at a young age followed by a rapid age-related cognitive decline (15). Inhibitory avoidance learning in 6-month-old GH-transgenic mice resembled values measured in 24-month-old normal animals (16). Thus, in GH transgenic mice, insulin resistance is associated with early and accelerated cognitive decline.

It is of possible interest in the context of this letter that glucocorticoid levels in GH transgenic mice are chronically elevated [reviewed in (17)], thus resembling findings in some affective disorders.

Although the observations summarized above are in excellent agreement with the proposal of Rasgon and Jarvik (1), the mechanisms responsible for these associations remain to be elucidated. It is presently unclear whether persistence of youthful levels of cognitive function in Ames dwarf and GHR-KO mice and early cognitive decline in GH transgenics are due to altered levels and actions of insulin or glucose within the brain. It is possible that differences between cognitive function of mutant, transgenic, and normal mice are due to one or more multiple secondary consequences of altered insulin resistance, or represent biomarkers of delayed aging in Ames dwarf and GHR-KO mice (4,18) and the apparently accelerated aging in GH transgenic mice (17). Regardless of the mechanisms involved, it is clear that, in mice, differences in insulin sensitivity are associated with major alterations in cognitive aging.

References

  1. Rasgon N, Jarvik L. Insulin resistance, affective disorders, and Alzheimer's disease: review and hypothesis. J Gerontol Med Sci. 2004;59A:178-183.
  2. Borg KE, Brown-Borg HM, Bartke A. Assessment of the primary adrenal cortical and pancreatic hormone basal levels in relation to plasma glucose and age in the unstressed Ames dwarf mouse. Proc Soc Exp Biol Med. 1995;210:126-133.[Abstract]
  3. Zhou H, He L, Baumann G, Kopchick JJ. A mammalian model for Laron syndrome produced by targeted disruption of the mouse growth hormone receptor/binding protein gene (The Laron mouse). Proc Nat Acad Sci U S A. 1997;94:13215-13220.[Abstract/Free Full Text]
  4. Coschigano KT, Holland AN, Riders ME, List EO, Flyvbjerg A, Kopchick, JJ. Deletion, but not antagonism, of the mouse growth hormone receptor results in severely decreased body weights, insulin, and insulin-like growth factor I levels and increased life span. Endocrinology. 2003;144:3799-3810.[Abstract/Free Full Text]
  5. Hauck SJ, Hunter WS, Danilovich N, Kopchick JJ, Bartke A. Reduced levels of thyroid hormones, insulin, and glucose, and lower body core temperature in the growth hormone receptor/binding protein knockout mouse. Exp Biol Med. 2001;226:552-558.[Abstract/Free Full Text]
  6. Dominici FP, Arostegui Diaz G, Bartke A, Kopchick JJ, Turyn D. Compensatory alterations of insulin signal transduction in liver of growth hormone receptor knockout mice. J Endocrinol. 2000;166:579-590.[Abstract]
  7. Dominici FP, Hauck S, Argentino DP, Bartke A, Turyn D. Increased insulin sensitivity and upregulation of insulin receptor, insulin receptor substrate (IRS)-I and IRS-2 in liver of Ames dwarf mice. J Endocrinol. 2002;173:81-94.[Abstract]
  8. Coschigano KT, Kopchick JJ. Identification of genes potentially involved in kidney protection during diabetes. Endocrine Soc Abstr. 2000;82:P333.
  9. Kinney BA, Coschigano KT, Kopchick JJ, Bartke A. Evidence that age-induced decline in memory retention is delayed in growth hormone resistant GH-R-KO (Laron) mice. Physiol Behav. 2001;72:653-660.[Medline]
  10. Kinney BA, Meliska CJ, Steger RW, Bartke A. Evidence that Ames dwarf mice age differently from their normal siblings in behavioral and learning and memory parameters. Hormones Behav. 2001;39:277-284.[Medline]
  11. Kinney-Forshee BA, Kinney NE, Steger RW, Bartke A. Could a deficiency in growth hormone signaling be beneficial to the aging brain? Physiology Behav. 2004;80:589-594.[Medline]
  12. Sanz A, Bartke A, Barja G. Long-lived Ames dwarf mice: oxidative damage to mitochondrial DNA in heart and brain. J Am Aging Assn. 2002;25:119-122.
  13. Dominici FP, Cifone D, Bartke A, Turyn D. Loss of sensitivity to insulin at early events of the insulin signaling pathway in the liver of growth hormone-transgenic mice. J Endocrinol. 1999;161:383-392.[Abstract]
  14. Dominici FP, Cifone D, Bartke A, Turyn D. Alterations in the early steps of the insulin-signaling system in skeletal muscle of GH-transgenic mice. Am J Physiol. 1999;277:E447-E454.
  15. Lemon JA, Boreham DR, Rollo CD. A dietary supplement abolishes age-related cognitive decline in transgenic mice expressing elevated free radical processes. Exp Biol Med. 2003;228:800-810.[Abstract/Free Full Text]
  16. Meliska CJ, Burke PA, Bartke A, Jensen RA. Inhibitory avoidance and appetitive learning in aged normal mice: comparison with transgenic mice having elevated plasma growth hormone levels. Neurobiol Learn Memory. 1997;68:1-12.[Medline]
  17. Bartke A. Can growth hormone (GH) accelerate aging? Evidence from GH-transgenic mice. Neuroendocrinology. 2003;78:210-216.[Medline]
  18. Brown-Borg HM, Borg KE, Meliska CJ, Bartke A. Dwarf mice and the ageing process. Nature. 1996;384:33.[Medline]




This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bartke, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bartke, A.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
All GSA journals The Gerontologist
Journals of Gerontology Series B: Psychological Sciences and Social Sciences